MD Newsline Oncology Brief

In this episode of MD Newsline, Dr. Eleonora Teplinksy, a breast and gynecologic medical oncologist at Valley Health System and clinical assistant professor at the Icahn School of Medicine at Mount Sinai, shares key updates from the ASCO annual meeting. She discusses transformative clinical trials that are reshaping the landscape of metastatic breast cancer treatment across subtypes including horm...

In this episode of MD Newsline, Dr. Ashley Sumrall, a neuro-oncologist and Section Chief at Atrium Health Levine Cancer Institute, shares groundbreaking insights into the treatment of diffuse midline gliomas with the H3K27M mutation. Dr. Sumrall presents data from pediatric and adult studies using Dordaviprone (ONC201), highlighting its promising response rates and tolerability. She also discusses...

In this episode of MD Newsline, Dr. Karine Tawagi, a genitourinary medical oncologist at the University of Illinois in Chicago, shares cutting-edge updates from ASCO 2024 related to bladder, prostate, and kidney cancers. Dr. Tawagi explores the clinical implications of circulating tumor DNA (CT DNA), discusses evolving bladder preservation strategies, and addresses the expanding role of PARP inhib...

In this episode of MD Newsline, Dr. Elias Jabbour, Professor of Medicine at MD Anderson Cancer Center, shares groundbreaking insights into the evolving treatment landscape of chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myeloid leukemia (AML). He discusses the transformative role of tyrosine kinase inhibitors (TKIs), strategies to achieve treatment-free remission,...

In this episode of MD Newsline, Dr. Diego Marzese, a breast cancer researcher specializing in epigenetics, explores how gene expression changes impact tumor behavior, treatment response, and disease progression. He discusses groundbreaking findings on how tumors activate or deactivate genetic alterations at different stages, the role of ethnicity in epigenetic variations, and how AI and machine le...

In this episode of MD Newsline, Dr. Ashley Sumrall, a physician specializing in neuro-oncology, explores the challenges and innovations in the field of brain tumor research and treatment. She discusses disparities in care, the role of tumor profiling in personalized medicine, and the impact of AI on imaging and diagnostics. Dr. Sumrall also highlights the devastating effects of drug shortages, the...

In this episode of MD Newsline, Dr. Oluwakemi Onajin, a board-certified dermatologist and dermatopathologist at the University of Chicago, discusses hidradenitis suppurativa (HS)—a chronic, inflammatory skin disease that is often misdiagnosed and takes years for patients to receive proper treatment. She explains the underlying causes of HS, the impact of genetics, hormones, and environmental facto...

In this episode of MD Newsline, Dr. Simone Nardin, a medical oncology fellow at the University of Genoa, discusses his research on ovarian suppression in premenopausal women undergoing endocrine therapy for luminal early breast cancer. His award-winning study explores the challenges of suboptimal ovarian suppression, its impact on treatment outcomes, and the need for longer follow-up and more freq...

In this episode of MD Newsline, Dr. Frank Weinberg, a thoracic oncologist at the University of Illinois Cancer Center, explores the latest advancements in lung cancer research. He shares insights on the role of biomarkers in early detection and treatment, the impact of COVID-19 on cancer immunology, and how machine learning is transforming oncology. Dr. Weinberg also discusses the importance of di...

In this episode of MD Newsline, Laura Crandon, Founder and President of Touch4Life and a two-time breast cancer survivor, shares her powerful journey from diagnosis to advocacy. Drawing from her lived experience with metastatic breast cancer, Laura highlights critical disparities in breast cancer outcomes—particularly among Black women—and the urgent need for equitable access to screening, testing...